Rethinking the role of bisphosphonates after denosumab treatment in locally advanced or unresectable aneurysmal bone cysts: A meta-analysis
BPs used in post-denosumab ossifying ABCs appear to improve treatment outcomes, presumably by targeting residual tumor cells. Prospective clinical studies are warranted to validate this promising two-stage conceptual strategy in difficult-to-treat ABC.
Authors
- Gennady N. Machak (ORCID: https://orcid.org/0000-0003-1222-5066)
- Øyvind S. Bruland (ORCID: https://orcid.org/0000-0003-1631-3733)
- Kovalev Av (ORCID: https://orcid.org/0000-0003-1277-5228)
- С. С. Родионова (ORCID: https://orcid.org/0000-0002-2726-8758)
Institutions
- Oslo University Hospital (NO)
- Norwegian Cancer Society (NO)
- Central Scientific Research Institute of Traumatology and Orthopedics (RU)
- National Medical Research Center of Cardiology (RU)
Publication Details
- Journal
- World Journal of Orthopedics
- Published
- 2025-08-08
- DOI
- https://doi.org/10.5312/wjo.v16.i8.107083
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00